FZROX
Price
$22.17
Change
+$0.15 (+0.68%)
Updated
Aug 8 closing price
Net Assets
28.65B
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

FZROX vs VSTSX

Header iconFZROX vs VSTSX Comparison
Open Charts FZROX vs VSTSXBanner chart's image
Fidelity ZERO Total Market Index
Price$22.17
Change+$0.15 (+0.68%)
VolumeN/A
Net Assets28.65B
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
FZROX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FZROX vs. VSTSX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZROX is a StrongBuy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. FZROX (28.7B). VSTSX pays higher dividends than FZROX: VSTSX (1.20) vs FZROX (1.07). FZROX was incepted earlier than VSTSX: FZROX (7 years) vs VSTSX (9 years). VSTSX (0.01) is less costly to investors than FZROX (0.00). FZROX (2.00) and VSTSX (2.00) have comparable annual turnover. FZROX has a lower initial minimum investment than VSTSX: FZROX (0) vs VSTSX (5000000000). FZROX annual gain was more profitable for investors over the last year : 21.31 vs. VSTSX (19.70). FZROX return over 5 years is better than : 99.51 vs. VSTSX (85.11).
FZROXVSTSXFZROX / VSTSX
Total Expense Ratio0.000.01-
Annual Report Gross Expense Ratio0.000.01-
Fund Existence7 years9 years-
Gain YTD8.8378.088109%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets28.7B1.91T2%
Annual Yield % from dividends1.071.2089%
Returns for 1 year21.3119.70108%
Returns for 3 years59.2852.05114%
Returns for 5 years99.5185.11117%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited